ALB and COVID-19: where a decrease in albumin level was associated with increased mortality, in-hospital complications, and longer hospital and ICU stays, and improvement in overall in-hospital outcomes with albumin replacement therapy in ARDS and ARF related to COVID-19 and pneumonia [14,15,43–45].